Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Graft vs Host Disease 1Cytopenia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 8Whole-Body Irradiation 7fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5fludarabine 4Tacrolimus 4Melphalan 4Busulfan 4Stem Cell Transplantation 2Sirolimus 2nicotinamide-beta-riboside 1methanesulfonic acid 1daratumumab 1X-Rays 1Valganciclovir 1Transplantation 1Therapeutics 1Specimen Handling 1Radiotherapy 1Polymerase Chain Reaction 1Passive Cutaneous Anaphylaxis 1Morphine 1Methotrexate 1Methadone 1Mesna 1Influenza Vaccines 1Hydromorphone 1Honey 1Hematopoietic Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Emapalumab × 1 year × Clear all
NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
35 enrolled
Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡